4TEEN4 Pharmaceuticals GmbH
Neuendorfstrasse 15a, 16761 Hennigsdorf, Germany
About the sponsor
The sponsor demonstrates a concentrated focus on developing therapeutic interventions specifically designed for adolescent and young adult cancer patients. This specialized demographic represents a unique population with distinct biological characteristics and treatment requirements that differ from both pediatric and adult oncology approaches. The research portfolio addresses the critical need for age-appropriate cancer therapies that account for the physiological and developmental aspects of patients in this transitional life stage.
- Targeted Cancer Therapeutics for Adolescents
- Young Adult Oncology Treatment Development
- Age-Specific Tumor Biology Research
The organization's commitment extends to understanding the unique pharmacokinetic profiles and treatment response patterns observed in adolescent and young adult populations, recognizing that this age group often experiences different disease progression and therapeutic outcomes compared to other patient demographics.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.